UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011144
Receipt number R000012990
Scientific Title Examination about the change of the cerebral blood flow before and after the treatment of the abstinence supplement using the cerebral blood flow scintigraphy
Date of disclosure of the study information 2013/08/01
Last modified on 2016/07/25 09:39:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination about the change of the cerebral blood flow before and after the treatment of the abstinence supplement using the cerebral blood flow scintigraphy

Acronym

Examination about the change of the cerebral blood flow for the treatment of the abstinence supplement

Scientific Title

Examination about the change of the cerebral blood flow before and after the treatment of the abstinence supplement using the cerebral blood flow scintigraphy

Scientific Title:Acronym

Examination about the change of the cerebral blood flow for the treatment of the abstinence supplement

Region

Japan


Condition

Condition

Alcoholism

Classification by specialty

Medicine in general Psychiatry Radiology
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We examine a change of the cerebral blood flow before and after the treatmen of the abstinence supplement (Regtect) in cerebral blood flow scintigraphy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

In this study, we intend for the patients who consulted an alcohol dependence treatment outpatient.
We intend for the patients with the abstinence will.
We use Regtect as abstinence adjuvant medicine.
Treatment using Regtect is provided.
We conduct a cognitive function evaluation and foreign follow-up before and after treatment.
The cerebral blood flow scintigraphy is carried out in a hospital nuclear medicine laboratory attached to the Osaka City University School of Medicine.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

We intend for the patients who consulted Kotani clinic for alcoholism.
They receive abstinence from alcoholic drinks treatment (including psycho-social therapy and rehabilitation such as the counseling), and we selects the patients who became the alcohol abstinence possible.
We give regtect in Kotani clinic subsequently.
We intend for the patients who secession from alcohol dependence is done and can continue abstinence from alcoholic drinks.

Key exclusion criteria

The patients who drank again during abstinence from alcoholic drinks treatment. The patients who stopped going to hospital and treatment by oneself.
The patients who were not able to undergo cerebral blood flow scintigraphy.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shigeaki Higashiyama

Organization

Osaka City University, Graduate School of Medicine

Division name

Nuclear Medicine

Zip code


Address

1-4-3 Asahimachi Abeno-ku Osaka-city Osaka

TEL

06-6645-3885

Email

higashiya@med.osaka-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shigeaki Higashiyama

Organization

Osaka City University, Graduate School of Medicine

Division name

Nuclear Medicine

Zip code


Address

1-4-3 Asahimachi Abeno-ku Osaka-city Osaka

TEL

06-6645-3885

Homepage URL


Email

higashiya@med.osaka-cu.ac.jp


Sponsor or person

Institute

Osaka City University, Graduate School of MedicineDepartment of Nuclear Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 08 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 08 Month 01 Day

Last follow-up date

2015 Year 12 Month 01 Day

Date of closure to data entry

2016 Year 07 Month 28 Day

Date trial data considered complete

2016 Year 07 Month 28 Day

Date analysis concluded

2016 Year 09 Month 28 Day


Other

Other related information

We compare the cerebral blood flow before and after the treatment of the abstinence in alcoholism.
We determine the association between alcoholism and intracerebral local blood flow change site.
The objective effect of treatment judgment, effect of treatment response prediction is enabled.
We evaluate an intracerebral blood flow change by Regtect.


Management information

Registered date

2013 Year 07 Month 08 Day

Last modified on

2016 Year 07 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012990


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name